Kurt R. Stenmark

Active 1983–2025

146
Papers
24,430
Citations
85
h-index
142
i10-index

Citations

Citations per year for Kurt R. Stenmark1984: 3 citations1985: 2 citations1986: 3 citations1987: 1 citations1988: 2 citations1989: 7 citations1990: 7 citations1991: 5 citations1992: 14 citations1993: 8 citations1994: 8 citations1995: 16 citations1996: 24 citations1997: 38 citations1998: 33 citations1999: 53 citations2000: 63 citations2001: 68 citations2002: 60 citations2003: 60 citations2004: 93 citations2005: 82 citations2006: 142 citations2007: 129 citations2008: 142 citations2009: 137 citations2010: 205 citations2011: 175 citations2012: 192 citations2013: 193 citations2014: 216 citations2015: 197 citations2016: 240 citations2017: 211 citations2018: 248 citations2019: 739 citations2020: 950 citations2021: 908 citations2022: 705 citations2023: 516 citations2024: 918 citations2025: 438 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,623 citing papers, 30.4% of this breakdownChina: 1,341 citing papers, 15.5% of this breakdownUnited Kingdom: 578 citing papers, 6.7% of this breakdownGermany: 506 citing papers, 5.9% of this breakdownCanada: 395 citing papers, 4.6% of this breakdownFrance: 394 citing papers, 4.6% of this breakdownNetherlands: 238 citing papers, 2.8% of this breakdownItaly: 217 citing papers, 2.5% of this breakdownJapan: 214 citing papers, 2.5% of this breakdownAustralia: 159 citing papers, 1.8% of this breakdownSwitzerland: 144 citing papers, 1.7% of this breakdownSpain: 143 citing papers, 1.6% of this breakdown
0%30.4%Other 19.4%

Fields

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology26.6%
  • Immunology and Microbiology5.4%
  • Neuroscience1.3%
  • Engineering1.2%
  • Nursing0.9%
  • Other1.8%

Topics

  • Pulmonary Hypertension Research and Treatments13.7%
  • Neonatal Respiratory Health Research2.8%
  • Cancer, Hypoxia, and Metabolism2.8%
  • Cardiovascular Function and Risk Factors2%
  • MicroRNA in disease regulation1.8%
  • Nitric Oxide and Endothelin Effects1.8%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

    Authors: , , , , , , , , , , - European Respiratory Journal 2018 cited by 1,274

  2. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia

    Authors: , , , - Redox Biology 2022 cited by 207

  3. Pediatric Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2015 cited by 1,128

  4. Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 553

  5. Contribution of metabolic reprogramming to macrophage plasticity and function

    Authors: , - Seminars in Immunology 2015 cited by 264

  6. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 262

  7. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2017 cited by 249

  8. The Adventitia: Essential Regulator of Vascular Wall Structure and Function

    Authors: , , , , , , , - Annual Review of Physiology 2012 cited by 434

  9. Cellular and molecular pathobiology of pulmonary arterial hypertension

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 1,564

  10. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

    Authors: , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2009 cited by 770

  11. The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension

    Authors: , , , , , , , , - International Journal of Molecular Sciences 2021 cited by 84

  12. Hypoxia-Induced Pulmonary Vascular Remodeling

    Authors: , , - Circulation Research 2006 cited by 997

  13. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 122

  14. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2019 cited by 118

  15. Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy

    Authors: , , , , , , , - British Journal of Pharmacology 2019 cited by 112

  16. Cellular and Molecular Basis of Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 812

  17. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2009 cited by 720

  18. 17β-estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2021 cited by 115

  19. Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 579

  20. Pathology and pathobiology of pulmonary hypertension: current insights and future directions

    Authors: , , , , , , , , , - European Respiratory Journal 2024 cited by 136

  21. Platelet activation contributes to hypoxia-induced inflammation

    Authors: , , , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2020 cited by 55

  22. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , - Circulation Research 2015 cited by 289

  23. Chemotherapy-Induced Pulmonary Hypertension

    Authors: , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2014 cited by 209

  24. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes

    Authors: , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2014 cited by 209